BIOLASE Inc news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

BIOL 0.860 +0.078 (9.96%)
price chart
BIOLASE Inc (BIOL) Major Shareholder Jack W. Schuler Purchases 24200 Shares of ...
BIOLASE logo BIOLASE Inc (NASDAQ:BIOL) major shareholder Jack W. Schuler purchased 24,200 shares of the company's stock in a transaction that occurred on Wednesday, January 20th.
BIOLASE Inc (NASDAQ:BIOL) SVP / Chief Financial Officer David Dreyer ...
BIOLASE Inc (NASDAQ:BIOL) 0.771 -0.034 -4.16% 's SVP / Chief Financial Officer, David Dreyer, bought 5,000 shares of stock in the public company.
The Insider and SVP / Chief Financial Officer of BIOLASE Inc (NASDAQ:BIOL ...  FinancialBio.com
Price Target Update On Biolase, Inc. (BIOL)
05/13/2014 - Biolase, Inc. was downgraded to “hold” by analysts at WallachBeth Capital. They now have a USD 2.5 price target on the stock.
Insider Buying: BIOLASE Inc (BIOL) Major Shareholder Acquires $18150.00 in Stock
BIOLASE logo BIOLASE Inc (NASDAQ:BIOL) major shareholder Jack W. Schuler purchased 24,200 shares of BIOLASE stock in a transaction that occurred on Wednesday, January 20th.
BIOLASE Inc (BIOL): Biolase: Management's Statements At Odds With The Facts
Biolase has also tried to create a false boogeyman of "illegal naked short sellers" even though there is demonstrably no naked short selling going on with the stock.
Related articles »  
Jack W. Schuler Purchases 24200 Shares of BIOLASE Inc (BIOL) Stock
BIOLASE logo BIOLASE Inc (NASDAQ:BIOL) major shareholder Jack W. Schuler purchased 24,200 shares of BIOLASE stock in a transaction dated Wednesday, January 20th.
Biolase: Why Your Dentist Is Short This Stock
In doing the background research on a microcap long position that I'm heavily invested in, LED Medical Diagnostics Inc (OTCQX:LEDIF) - which is currently up 14.3% and has traded as high as 33% from my initiation, I came across a comparable peer that I ...
Company Shares of Biolase, Inc. (NASDAQ:BIOL) Rally 21.43%
Shares of Biolase, Inc. (NASDAQ:BIOL) rose by 21.43% in the past week and 11.38% for the last 4 weeks. In the past week, the shares has outperformed the S&P 500 by 19.34% and the outperformance increases to 17.33% for the last 4 weeks.
Oracle Partners Announces Its Proxy Contest Against Biolase, Inc.
GREENWICH, Conn., March 11, 2014 /PRNewswire/ -- Oracle Partners, L.P. ("Oracle"), Biolase, Inc.'s ("Biolase" or the "Company") (Nasdaq: BIOL) largest shareholder, announces its nomination of four independent directors for election to the Biolase Board ...
Related articles »  
BIOLASE Comments on Recent Decline in Stock Price
BIOLASE, Inc. is a medical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office ...
Biolase Jumps on CEO Comments  Orange County Business Journal